You just read:

Merck KGaA, Darmstadt, Germany Presents Updated Clinical Results for Bifunctional Immunotherapy M7824 at ASCO 2018

News provided by

Merck KGaA, Darmstadt, Germany

Jun 04, 2018, 08:15 ET